Minneapolis Heart Institute

Minneapolis, Minnesota 55414

13 studies enrolling now · 93 studies all time

What they study most

Abdominal Aortic Aneurysm (AAA), Activated Clotting Time, Acute Coronary Syndrome, Acute Decompensated Heart Failure, Acute Kidney Injury (AKI), Acute Myocardial Infarction, Advanced Refractory Left Ventricular Heart Failure, Adverse Effect of MRI on an Implanted Pacemaker, Adverse Effect of MRI on an Implanted Pacemaker Lead, Anemia, Angina, Angina Pectoris

Studies at this site

• A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial) — Recruiting now
• FORWARD CAD IDE Study — Recruiting now
• An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) — Recruiting now
• CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3) — Recruiting now
• SELUTION 4 De Novo Small Vessel IDE Trial — Recruiting now
• ELEVATE High-Risk PCI Pivotal Study — Recruiting now
• BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT — Recruiting now
• Cephea Early Feasibility Study — Recruiting now
• A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis — Recruiting now
• Abbott Cephea Mitral Valve Disease Registry — Recruiting now
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure — Recruiting now
• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF) — Recruiting now
• Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) — Recruiting now
• US National OCS Heart Perfusion (OHP) Registry — Recruiting now
• The HALT Biomarker Study — Recruiting now
• Portico Next Generation Approval Study — Running, not enrolling
• Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events — Running, not enrolling
• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• A Study of the ReCor Medical Paradise System in Clinical Hypertension — Running, not enrolling
• AMPLATZER PFO Occluder Post Approval Study — Running, not enrolling
• Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI) — Completed
• Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions — Completed
• PARADIGM: Amplatzer Valvular Plug for PVL Closure — Running, not enrolling
• Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population — Running, not enrolling
• A Study of Acute Myocardial Infarction Using FDY-5301 — Completed
• SELUTION SLR™ 014 In-stent Restenosis — Running, not enrolling
• OCS Heart Perfusion Post-Approval Registry — Running, not enrolling
• Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome — Completed
• OCS DCD Heart + CAP Continued Follow-Up — Running, not enrolling
• CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — Running, not enrolling
• Hemodynamic-GUIDEd Management of Heart Failure — Completed
• Optisure Lead Post Approval Study — Stopped early
• Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Running, not enrolling
• Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System — Completed
• Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States — Completed
• The ARIES HeartMate 3 Pump IDE Study — Completed
• International EXPAND Heart Pivotal Trial — Completed
• Heart EXPAND Continued Access Protocol — Completed
• Abbott Next Generation Drug Eluting Stent 48mm Study — Completed
• Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery — Completed
• Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) — Running, not enrolling
• ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) — Completed
• Donor After Circulatory Death Heart CAP Trial — Completed
• Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis — Stopped early
• EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis — Running, not enrolling
• Donors After Circulatory Death Heart Trial — Completed
• Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial — Running, not enrolling
• Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy — Completed
• Disrupt CAD III With the Shockwave Coronary IVL System — Completed
• Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy — Stopped early